RICHMOND - Turmeric, an ingredient found in common kitchen spices,  combined with anti-nausea medication thalidomide effectively kills  cancer cells, researchers at VCU Massey Cancer Center have discovered.
 In a laboratory, preclinical study, researchers combined structural  features from thalidomide with turmeric to create hybrid molecules that  effectively kill multiple myeloma cells.
 Thalidomide was first introduced in the 1950s as an anti-nausea  medication to help control morning sickness, but was later taken off  shelves because it was found to cause birth defects. In the late 1990s  the drug was re-introduced as a treatment for multiple myeloma. 
 Turmeric, a spice grown in India and other Asian areas, has a long  history of use in herbal remedies and has recently been studied as a  means to prevent and treat cancer, arthritis and Alzheimer's disease. 
 According to the American Cancer Society, laboratory studies have  shown that curcumin, an active ingredient in turmeric, interferes with  several important molecular pathways and inhibits the formation of  cancer-causing enzymes in rodents.
 Compared to mixing multiple drugs, creating hybrid molecules can  provide certain advantages including enhanced potency, reduced risk of  developing drug resistance, reduced cost and improved patient compliance  according to researchers
 
No comments:
Post a Comment